Brief: Eckert & Ziegler And Glytherix Extend Collaboration With Actinium-225 Supply Agreement
Jan 13 (Reuters) - ECKERT & ZIEGLER SE EUZG.DE :
* AND GLYTHERIX EXTEND COLLABORATION WITH ACTINIUM-225
SUPPLY
AGREEMENT
* TO SUPPLY AC-225 FOR GLYTHERIX CLINICAL RESEARCH
* GLYTHERIX TO USE 177LU-DOTA-MILTUXIMAB IN AUSTRALIAN PHASE
IB IN
EARLY 2025
* AC-225 MANUFACTURING EXPECTED TO BE FINALIZED IN FIRST
HALF OF
2025
Source text: ID:nEQ75xdhSa
Further company coverage: EUZG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth